Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

141.82 UNCHANGED
Delayed Quote Updated: 7:00 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Merck (MRK) reports Q3: everything you need to know ahead of earnings
Global pharmaceutical company Merck (NYSE:MRK) will be reporting earnings this Thursday before market open. Here’s what investors should know. Merck beat ana... 
Via StockStory
Topics Artificial Intelligence
News headline image
Merck and Moderna's Cancer Vaccine Worked—Who Gets Paid? ↗
Merck and Moderna's melanoma vaccine cut recurrence risk 42% in a Phase 3 trial, but results fell short of hopes, sending Moderna shares down sharply while Merck stock barely moved. 
Via MarketBeat
News headline image
Merck Highlights Phase III Cancer Wins, Eyes 2027 Oncology Pipeline Catalysts ↗
Merck & Co., Inc. (NYSE:MRK) outlined new oncology data and development plans at the European Society for Medical Oncology annual meeting, highlighting phase III results for its sacituzumab... 
Via MarketBeat
S&P 500 Top Movers: Gainers and Losers in Today's US Session ↗
Via Chartmill
Topics Stocks
Dow Jones Top Gainers in Today's Session: 3M Leads ↗
Via Chartmill
Topics Stocks
Dow Jones Top Gainers on Oct. 20, 2026: MMM, UNH, MRK Lead Session ↗
Via Chartmill
Topics Stocks
Merck (NYSE:MRK) Nears Breakout Setup With Strong Technical Ratings ↗
Via Chartmill
News headline image
Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts ↗
MercadoLibre, Novo Nordisk, Tyler Technologies and Summit Therapeutics trade below recent highs, yet each has earnings or catalysts that could shift sentiment. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
KEYTRUDA® (pembrolizumab) as Monotherapy Reduced the Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
From Merck & Co., Inc.
Via Business Wire
News headline image
Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Certain Patients With Advanced or Recurrent Endometrial Cancer
From Merck & Co., Inc.
Via Business Wire
Merck & Co. (NYSE:MRK): A Quality Investing Case With Strong ROIC but Revenue Growth Concerns ↗
Via Chartmill
News headline image
A Personalized Cancer Therapy Delivered Positive Phase 3 Results; The Next Race Is Picking Better Targets
News Provided by Biotech Insider on behalf of MindWalk Holdings Corp. 
From Biotech Insider
Via GlobeNewswire
News headline image
3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach ↗
Lincoln National, AbbVie and Phillips 66 offer dividends that pay investors through midterm volatility, backed by rising rates, steady drug demand and oil risk. 
Via MarketBeat
News headline image
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
From Merck & Co., Inc.
Via Business Wire
News headline image
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
Growing investment in next-generation CNS cancer therapies is driving research into targeted drugs, immunotherapy and new approaches to treating aggressive brain tumors. 
From FN Media
Via GlobeNewswire
News headline image
Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
EQNX::TICKER_START (NASDAQ:NTHI),(NASDAQ:NBIX),(NASDAQ:ACAD),(NASDAQ:AVXL),(NYSE:MRK) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026 ↗
The market has rewarded this biotech for its breakthroughs. 
Via The Motley Fool
News headline image
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
From Merck & Co., Inc.
Via Business Wire
News headline image
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice ↗
This company made headlines with its coronavirus vaccine. 
Via The Motley Fool
News headline image
2 High-Flying Dividend Stocks to Buy and Hold for a Decade ↗
They may just be getting started. 
Via The Motley Fool
Topics Intellectual Property
News headline image
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning ↗
AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys ↗
These funds can help you weather any storm that might be on the way. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Novo Nordisk and Eli Lilly Just Got Some Fantastic News ↗
A new government-funded study found that GLP-1 drugs slow the aging process in mice. 
Via The Motley Fool
Discover which dow jones stocks are making waves on Thursday. ↗
Via Chartmill
Stock Market Today: Hot Inflation and a Neocloud Shakeout Sink the Nasdaq ↗
Via Chartmill
Topics Economy
Discover which dow jones stocks are making waves on Wednesday. ↗
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.